header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

MEDIUM TERM OUTCOME OF PFM/REVITAN UNCEMENTED MODULAR TITANIUM FEMORAL COMPONENTS IN TOTAL HIP REVISION

Australian Orthopaedic Association and New Zealand Orthopaedic Association (AOA/NZOA) - Combined Annual Scientific Meeting



Abstract

Revision total hip replacement may be technically challenging, with component selection being one of the challenges. Modular titanium femoral components have some advantages, and our aim was to assess the medium term outcome of the use of such a component [Revitan or PFM]

We reviewed 323 patients undergoing revision with one of these femoral stems. We applied the Oxford Hip Score, the Charnley Class, and the Devane Patient Activity Level to each patient.

The average follow up time was 6.58 years. The mean Oxford score was 35.74.39.8% of the patients were Charnley Class B. 52.4% of patients had an activity score indicating a moderate level of activity ie they could participate in gardening, swimming and other leisure pursuits.

The overall outcome was good with this prosthesis. The Oxford scores were comparable with the national mean for revision THR on the NZ National Joint Register.